2008 WHO classification Acute erythroid leukemia: a reassessment using criteria refined in the

[1]  F. Naeim.  8 – Myelodysplastic Syndromes/Neoplasms—Overview , 2013 .

[2]  H. Kantarjian,et al.  Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution , 2009, Leukemia.

[3]  H. Koeppen,et al.  Application of COLD-PCR for improved detection of KRAS mutations in clinical samples , 2009, Modern Pathology.

[4]  J. Merker,et al.  Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system. , 2008, Blood.

[5]  B. Woda,et al.  Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification , 2008, Modern Pathology.

[6]  A. Hagemeijer,et al.  Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  G. Ehninger,et al.  MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients. , 2008, Blood.

[8]  Thomas H Müller,et al.  New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. , 2007, Blood.

[9]  L. Medeiros,et al.  Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia. , 2006, American journal of clinical pathology.

[10]  U. Germing,et al.  Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals , 2006, British journal of haematology.

[11]  R. Berger,et al.  Cytogenetic study of 75 erythroleukemias. , 2005, Cancer genetics and cytogenetics.

[12]  E. Estey,et al.  Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias , 2005, Leukemia.

[13]  U. Germing,et al.  Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals. , 2003, Leukemia research.

[14]  C. Ross,et al.  Diagnostic criteria for acute erythroleukemia. , 2003, Blood.

[15]  M. Labopin,et al.  Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT). , 2002, Blood.

[16]  F. Picard,et al.  Erythroleukemia: a need for a new definition , 2002, Leukemia.

[17]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[18]  N. Harris,et al.  Acute myeloid leukaemia not otherwise categorised. . , 2001 .

[19]  K Wheatley,et al.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.

[20]  L. Kanter‐Lewensohn,et al.  Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. , 1997, Leukemia research.

[21]  T Hamblin,et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[22]  O. Olopade,et al.  Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. , 1992, Blood.

[23]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.